Abstract
Uganda’s rising HIV epidemic is a cause of concern. HIV prevalence has increased from 6.4 to 7.3 % in a space of 6 years (2005–2011), and the number of new HIV infections in adults and children is estimated to have increased from 130,000 in 2010 to 145,000 in 2011 based on results from mathematical models. In order to reverse this trend, Uganda has adopted a national combination HIV prevention approach that involves implementation of biomedical, behavioral, and structural interventions at a scale, quality, and intensity necessary to impact the epidemic. This chapter discusses Uganda’s progress in implementing biomedical HIV prevention interventions, including HIV counseling and testing (HCT), voluntary medical male circumcision (VMMC), antiretroviral therapy (ART), and prevention of mother-to-child transmission (PMTCT) of HIV. Modeling studies suggest that the coverage of these interventions should reach 80–90 % of the adult population if Uganda is to reverse the current epidemic trends by 2015. Reports from the Ugandan Ministry of Health suggest that the coverage of HCT, PMTCT and ART services has increased over the past 5 years. For instance, the percentage of health facilities (HFs) offering HCT has increased from 37 % in 2009/10 to 38 % in 2011/12. The percentage of HFs offering PMTCT services has also increased from 23 % in 2009/10 to 36% in 2011/12. By the end of 2012, approx. 24 % of 4,493 HFs in Uganda were actively offering ART. Despite this level of coverage, only 26 % of Ugandan men are circumcised, 73 % of eligible HIV-positive patients receive antiretrovirals (ARVs), 87.4 % of all HIV-positive pregnant women identified at antenatal clinics, during labor and delivery, and during the post-natal period receive prophylactic ART to reduce the risk of mother-to-child transmission of HIV (constituting approx. 52 % of all expected HIV-positive pregnant women in Uganda), while 34 % of women and 55 % of men are not aware of their HIV status. Several challenges still inhibit national scale-up of these interventions, including the slow progress in translation of research into policy, lack of adequate resources to put everybody who is eligible for ART on treatment, and the fact that the majority of Ugandans present late for HIV diagnosis, and therefore enter late (with lower CD4 cell counts) into HIV care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Government health facilities are graded into Health Centers and Hospitals, depending on the population and geographical areas served. The lowest level facility is Health Center I (HC I) which serves the village level, approximately 1,000 people. From HC I, the assignment of levels increases in grade as the population and geographical areas served increase—from HC II (which serves a parish, approximately 5,000 people) through HC III (which serves a subcounty, approximately 20,000 people) and HC IV (which serves a county, approximately 100,000 people) to a District Hospital (district level, approximately 500,000 people), Regional Referral Hospital (which serves approximately 3 million people or 3-5 districts), and National Referral Hospital, which serves approximately 10 million people.
- 2.
HCT was provided as a service to study participants. Therefore, HCT services were available to community residents who had participated in research and who had provided a blood sample. Approximately 15,000 adults (15–49 years) were followed up through annual HIV surveillance surveys conducted in 50 communities in Rakai district.
References
Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, et al. Slim disease: a new disease in Uganda and its association with HTLV-III Infection. Lancet. 1985;326(8460):849–52.
Slutkin G, Okware S, Naamara W, Sutherland D, Flanagan D, et al. How Uganda reversed its HIV epidemic. AIDS Behav. 2006;10(4):351–60.
Green EC, Halperin DT, Nantulya V, Hogle JA. Uganda’s HIV prevention success: the role of sexual behavior change and the national response. AIDS Behav. 2006;10(4):335–46.
Asiimwe-Okiror G, Opio AA, Musinguzi J, Madraa E, Tembo G, Carael M. Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS. 1997;11(14):1757–63.
Kirungi WL, Musinguzi J, Madraa E, Mulumba N, Callejja T, Ghys P, Bessinger R. Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviour. Sex Transm Infect. 2006 Apr;82:Suppl 1:i36–41.
Uganda Bureau of Statistics (UBOS) and ICF International Inc. Uganda AIDS Indicator Survey 2011. Kampala, Uganda/Calverton, Maryland: UBOS/ICF International Inc; 2012.
Kasamba I, Baisley K, Mayanja BN, Maher D, Grosskurth G. The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999–2009. Trop Med Int Health. 2012;17(8):e66–73.
Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155:209–16.
Ministry of Health and ORC Macro. Uganda HIV/AIDS Sero-behavioural Survey. Calverton, Maryland, USA: Ministry of Health/ORC Macro; 2006.
Wabwire-Mangen F, Odiit M, Kirungi W, Kaweesa Kisitu D. Modes of transmission study, analysis of HIV prevention response and modes of HIV transmission: the Uganda country synthesis report. Kampala, Uganda: GoU/UNAIDS/UAC; 2009.
UNAIDS. Knowledge is power: voluntary HIV counselling and testing in Uganda. Geneva: UNAIDS; June 1999.
Matovu JK, Gray RH, Makumbi F, Wawer MJ, et al. Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda. AIDS. 2005;19:503–11.
Were W, Mermin J, Bunnell R, Ekwaru JP, Kaharuza F. Home-based model for HIV voluntary counselling and testing. Lancet. 2003;361(9368):1569.
Wolff B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. Evaluation of a home-based voluntary counselling and testing intervention in rural Uganda. Health Policy Plann. 2005;20(2):109–16.
Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDS. 2010;24(11):735–41.
Sekandi JN, Sempeera H, List J, Mugerwa MA, Asiimwe S, Yin X, Whalen CC. High acceptance of home-based HIV counseling and testing in an urban community setting in Uganda. BMC Public Health. 2011;11:730.
Nuwaha F, Kasasa S, Wana G, Muganzi E, Tumwesigye E. Effect of home-based HIV counselling and testing on stigma and risky sexual behaviours: serial cross-sectional studies in Uganda. J Int AIDS Soc. 2012;15(2):17423.
Matovu JK, Kigozi G, Nalugoda F, Wabwire-Mangen F, Gray RH. The Rakai project counseling program experience. Trop Med Int Health. 2002;7(12):1064–67.
Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G, Gupta S, Grosskurth H, Jaffar S, Coutinho A, et al. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010;55(2):245–52.
UNAIDS. National AIDS programmes: a guide to monitoring and evaluation. Geneva: UNAIDS (UNAIDS/00.17E); 2000.
Were WA, Mermin JH, Wamai N, Awor AC, Bechange S, Moss S, Solberg P, Downing RG, Coutinho A, Bunnell RE. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2006;43(1):91–5.
Wanyenze R, Kamya M, Liechty CA, Ronald A, Guzman DJ, Wabwire-Mangen F, Mayanja-Kizza H, Bangsberg DR. HIV counseling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav. 2006;10(4):361–7.
Wanyenze RK, Nawavvu C, Namale AS, Mayanja B, Bunnell R, Abang B, et al. Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals. Bull World Health Organ. 2008;86:302–9.
Nakanjako D, Kamya M, Daniel K, Mayanja-Kizza H, Freers J, Whalen C, et al. Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda. AIDS Behav. 2007;11:753–58.
Baggeley R, Hensen B, Ajose O, Grabbe KL, et al. From caution to urgency: the evolution of HIV testing and counseling in Africa. Bull World Health Organ. 2012;90:652–8B.
Allen S, Tice J, Van de Perre P, Serufilira A, Hudes E, Nsengumuremyi F, et al. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ. 1992;304(6842):1605–09.
Dunkle KL, Stephenson R, Karita E, Kayitenkore K, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008;371:2183–91.
Ministry of Health (MoH). National couplesʼ HIV counseling and 2 communication strategy. Kampala: MoH; 2009.
Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2(11):e298.
Gray RH, Kigozi G, Serwadda D, Makumbi F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66.
Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007;369:643–56.
Reed JB, Njeuhmeli E, Thomas AG, Bacon MC, et al Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. J Acquir Immune Defic Syndr. 2012;60(Suppl. 3):S88–S95.
Ocero AA, Kisembo G, Ciccio L, Fullem A, Beal K. Scaling-up medical male circumcision for HIV prevention in a non-circumcising community. XIX International AIDS Conference, Washington, D.C. July 22–27, 2012. Abstract#: WEPE242.
Ndifuna M, Kironde S, Tibenderana E, Serumaga Mulema V, Mutesasira K. Moving from tens to thousands: how using multiple approaches in East Central Uganda is rapidly scaling-up voluntary medical male circumcision in traditionally non-circumcising areas. XIX International AIDS Conference, Washington, D.C. July 22–27, 2012. Abstract#: WEPE241.
Buwembo DR, Musoke R, Kigozi G, Ssempijja V, Serwadda D, Makumbi F, et al. Evaluation of the safety and efficiency of the dorsal slit and sleeve methods of male circumcision provided by physicians and clinical officers in Rakai, Uganda. BJU Int. 2012;109(1):104–8.
Kigozi G, Musoke R, Watya S, Kighoma N, et al. The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda. J Acquir Immune Defic Syndr. 2013 Apr 22 [Epub ahead of print].
Gray R, Kigozi G, Kong X, Ssempijja V, Makumbi F, Watya S, et al. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a post-trial follow-up study. AIDS. 2012;26(5):609–15.
Wawer MJ, Kigozi G, Serwadda D, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomized controlled trial. Lancet. 2009;374:229–37.
Baeten JM, Donnell D, Kapiga SH, et al. Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1 serodiscordant couples. AIDS. 2010;24(5):737–44.
Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(11):669–77.
Wawer MJ, Tobian AA, Kigozi G, Kong X, Gravitt PE, Serwadda D, Nalugoda F, Makumbi F, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet. 2011;377(9761):209–18.
Katabira E, Kamya M (edtors). National antiretroviral treatment and care guidelines for adults and children. Kampala, Uganda: Ministry of Health; 2003.
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354(9181):795–802.
WHO. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: WHO; 2012.
Commission UAIDS. Mid-term evaluation of the National HIV and AIDS Strategic Plan (2007/08–2011/12). Kampala: Uganda AIDS Commission; 2011.
Albert LM, Akol A, L’Engle K, Tolley EE, et al. Acceptability of male circumcision for prevention of HIV infection among men and women in Uganda. AIDS Care. 2011;23(12):1578–85.
Ministry of Health. Integrated national guidelines on antiretroviral therapy, prevention of mother to child transmission of HIV and infant & child feeding. Kampala, Uganda: Ministry of Health; 2011.
Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52(2):280–89.
Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, Sawires S, et al. Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One. 2011;6:e21794.
Jain V, Byonanebye D, Muhaawe J, Kabami J, Black D, et al. Patient attitudes toward initiating early antiretroviral therapy at high CD4+ cell counts above national guideline thresholds. XIX International AIDS Conference, Washington, D.C. July 22–27, 2012. Abstract#: TUPE081.
Wanyenze RK, Tumwesigye NM, Kindyomunda R, Beyeza-Kashesya J, Atuyambe L, et al. Uptake of family planning methods and unplanned pregnancies among HIV-infected individuals: a cross-sectional study among clients at HIV clinics in Uganda. J Int AIDS Soc. 2011;14:35.
Cohen MS, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, et al. HPTN 052 study team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.
Matsiko D. The Uganda country case study: enhancing health worker and health system performance. The Global Health Workforce Alliance; 2010.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Matovu, J., McGrath, N. (2014). Implementing Biomedical HIV Prevention Advances in Uganda. In: Eaton, L., Kalichman, S. (eds) Biomedical Advances in HIV Prevention. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8845-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8845-3_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8844-6
Online ISBN: 978-1-4614-8845-3
eBook Packages: MedicineMedicine (R0)